Prof. Romano
Silvestri is a Full Professor of Medicinal Chemistry at the Sapienza University
of Rome, Italy. He graduated cum laude from Sapienza University and completed
his Ph.D. studies in Pharmaceutical Sciences at the same University. Since
being recruited to the Department of Pharmaceutical Studies, he became
Assistant Professor (1991–1998) and Associate Professor (1998–2010). In 2008 he
moved to the Department of Drug Chemistry and Technologies, and in 2010 became
a Full Professor. In 2015 was a visiting professor at Emory University,
Department of Chemistry, Atlanta, USA (prof. Dennis Liotta), and in 2016 at
King’s College, London (UK). His research projects are mainly focused on the
drug design and synthesis of new biologically active chemical entities in the
areas of antitumor, antiviral or SNC drugs.
Research Keywords & Expertise
Drug design and synthe...
Antiviral or SNC drugs
The drug design is bas...
New procedures for the...
Fingerprints
5%
Drug design and synthesis of new biologically active chemical entities in the areas of antitumor
5%
The drug design is based on molecular models performed by either the internal unit or external research groups
5%
Antiviral or SNC drugs
5%
New procedures for the microwave-assisted synthesis and the highly automated purification of relevant pharmaceutical molecules
Short Biography
Prof. Romano
Silvestri is a Full Professor of Medicinal Chemistry at the Sapienza University
of Rome, Italy. He graduated cum laude from Sapienza University and completed
his Ph.D. studies in Pharmaceutical Sciences at the same University. Since
being recruited to the Department of Pharmaceutical Studies, he became
Assistant Professor (1991–1998) and Associate Professor (1998–2010). In 2008 he
moved to the Department of Drug Chemistry and Technologies, and in 2010 became
a Full Professor. In 2015 was a visiting professor at Emory University,
Department of Chemistry, Atlanta, USA (prof. Dennis Liotta), and in 2016 at
King’s College, London (UK). His research projects are mainly focused on the
drug design and synthesis of new biologically active chemical entities in the
areas of antitumor, antiviral or SNC drugs.